Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Amended on May 15, 2023 – the version known today is shown.

You are looking at Q4 2022. Go to the latest filing (Q3 2026)

26.0B USDQ4 2022
Total value of stock positions
26.0B USD
Positions
1,022
Share of the ten largest
14.3%

The ten largest positions Q4 2022

  1. Meta Platforms 2.2%▲ +140.7%
  2. Broadcom 1.7%▲ +166.0%
  3. Salesforce 1.7%new
  4. Amazon 1.6%▲ +174.8%
  5. Fidelity National Information Services 1.6%▲ +81.6%
  6. Biogen 1.3%▼ −26.9%
  7. Visa Inc. 1.2%▲ +32.7%
  8. Take-Two Interactive 1.1%▲ +80.1%
  9. Uber 0.9%▲ +18,546.7%
  10. Dominion Energy 0.9%▲ +197.1%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q4 2022

Positions Q4 2022 per 13F filing, 277 of 277
Symbol Weight Shares Reported value Change Held since
BIIB Biogen 1.3% 1,226,124 339.5M USD −26.9% reduced Q3 2020 10 quarters
ADI Analog Devices 0.9% 1,355,581 222.4M USD −4.7% reduced Q2 2020 11 quarters
ANET Arista Networks 0.8% 1,812,261 219.9M USD −8.4% reduced Q1 2021 8 quarters
BABA Alibaba Group (ADR) 0.7% 2,150,552 189.4M USD −39.1% reduced Q4 2021 5 quarters
ZBH Zimmer Biomet 0.6% 1,138,053 145.1M USD −11.6% reduced Q1 2022 4 quarters
YUM Yum! Brands 0.5% 1,075,502 137.8M USD −10.2% reduced Q1 2022 4 quarters
MSFT Microsoft 0.5% 505,525 121.2M USD −47.2% reduced Q1 2020 12 quarters
JBL Jabil 0.5% 1,776,900 121.2M USD −13.9% reduced Q2 2019 15 quarters
ORCL Oracle Corporation 0.5% 1,482,512 121.2M USD −50.7% reduced Q1 2022 4 quarters
AZN AstraZeneca 0.4% 1,539,490 104.4M USD −68.0% reduced Q1 2020 12 quarters
Inspire Med Sys Inc 0.4% 412,924 104.0M USD −15.5% reduced Q4 2020 9 quarters
MLM Martin Marietta Materials 0.4% 282,253 95.4M USD −5.4% reduced Q1 2021 8 quarters
Sarepta Therapeutics Inc 0.4% 703,755 91.2M USD −17.4% reduced Q1 2021 8 quarters
EL Estée Lauder Companies (The) 0.3% 360,707 89.5M USD −31.1% reduced Q1 2022 4 quarters
CB Chubb Limited 0.3% 387,634 85.5M USD −8.4% reduced Q2 2020 11 quarters
INTU Intuit 0.3% 202,055 78.6M USD −23.7% reduced Q3 2022 2 quarters
Canadian Nat Res Ltd 0.3% 1,409,900 78.3M USD −26.1% reduced Q1 2022 4 quarters
LVS Las Vegas Sands 0.3% 1,502,803 72.2M USD −31.7% reduced Q3 2018 18 quarters
TDY Teledyne Technologies 0.3% 176,628 70.6M USD −6.7% reduced Q3 2020 10 quarters
Antero Resources Corp 0.3% 2,256,115 69.9M USD −2.9% reduced Q3 2020 10 quarters
Anaptysbio Inc 0.3% 2,124,200 65.8M USD −15.9% reduced Q4 2021 5 quarters
Restaurant Brands Intl Inc 0.3% 1,007,245 65.1M USD −29.5% reduced Q3 2022 2 quarters
VMC Vulcan Materials Company 0.2% 361,626 63.3M USD −12.6% reduced Q1 2021 8 quarters
CRWD CrowdStrike 0.2% 600,220 63.2M USD −37.7% reduced Q4 2021 5 quarters
SHW Sherwin-Williams 0.2% 262,850 62.4M USD −4.5% reduced Q2 2022 3 quarters
VST Vistra Corp. 0.2% 2,666,835 61.9M USD −3.9% reduced Q1 2021 8 quarters
Fortune Brands Innovations I 0.2% 1,033,220 59.0M USD −24.4% reduced Q2 2021 7 quarters
Exact Sciences Corp 0.2% 1,173,909 58.1M USD −51.7% reduced Q3 2022 2 quarters
Stellantis N.v 0.2% 4,015,899 57.0M USD −3.7% reduced Q1 2022 4 quarters
UNP Union Pacific Corporation 0.2% 269,699 55.8M USD −32.2% reduced Q3 2022 2 quarters
CSCO Cisco 0.2% 1,164,965 55.5M USD −42.8% reduced Q3 2022 2 quarters
MNST Monster Beverage 0.2% 543,029 55.1M USD −72.6% reduced Q3 2021 6 quarters
Bellring Brands Inc 0.2% 2,144,220 55.0M USD −2.4% reduced Q1 2022 4 quarters
CRDO Credo Technology Group 0.2% 3,813,700 50.8M USD −4.0% reduced Q1 2022 4 quarters
TMUS T-Mobile US 0.2% 357,008 50.0M USD −84.4% reduced Q2 2020 11 quarters
RMD ResMed 0.2% 234,425 48.8M USD −41.1% reduced Q1 2022 4 quarters
Macys Inc 0.2% 2,304,731 47.6M USD −54.7% reduced Q2 2022 3 quarters
Xenon Pharmaceuticals Inc 0.2% 1,178,324 46.5M USD −28.2% reduced Q1 2015 32 quarters
Amedisys Inc 0.2% 551,468 46.1M USD −48.5% reduced Q3 2022 2 quarters
Ambarella Inc 0.2% 557,248 45.8M USD −56.9% reduced Q3 2021 6 quarters
Ascendis Pharma A/S 0.2% 374,710 45.8M USD −2.5% reduced Q3 2022 2 quarters
Chord Energy Corporation 0.2% 333,418 45.6M USD −5.6% reduced Q4 2021 5 quarters
HII Huntington Ingalls Industries 0.2% 192,900 44.5M USD −5.9% reduced Q4 2021 5 quarters
Krystal Biotech Inc 0.2% 556,252 44.1M USD −55.8% reduced Q2 2020 11 quarters
Avantor Inc 0.2% 2,069,355 43.6M USD −11.8% reduced Q1 2020 12 quarters
Victorias Secret And Co 0.2% 1,204,768 43.1M USD −24.0% reduced Q3 2021 6 quarters
MRK Merck & Co. 0.2% 352,873 39.2M USD −40.7% reduced Q2 2020 11 quarters
LUV Southwest Airlines 0.1% 1,158,193 39.0M USD −57.4% reduced Q4 2021 5 quarters
Healthequity Inc 0.1% 632,425 39.0M USD −6.8% reduced Q4 2021 5 quarters
MAT Mattel 0.1% 2,178,742 38.9M USD −10.9% reduced Q3 2020 10 quarters
Molina Healthcare Inc 0.1% 115,800 38.2M USD −33.3% reduced Q3 2022 2 quarters
Uniqure NV 0.1% 1,672,830 37.9M USD −60.7% reduced Q2 2020 11 quarters
AEE Ameren 0.1% 419,979 37.3M USD −40.0% reduced Q1 2022 4 quarters
HLT Hilton Worldwide 0.1% 287,364 36.3M USD −62.7% reduced Q4 2021 5 quarters
WAT Waters Corporation 0.1% 105,522 36.1M USD −11.4% reduced Q1 2022 4 quarters
BRO Brown & Brown 0.1% 625,404 35.6M USD −21.5% reduced Q2 2022 3 quarters
Valvoline Inc 0.1% 1,071,000 35.0M USD −14.2% reduced Q3 2021 6 quarters
Chinook Therapeutics Inc 0.1% 1,267,660 33.2M USD −48.1% reduced Q4 2020 9 quarters
Mastec Inc 0.1% 379,200 32.4M USD −37.1% reduced Q3 2022 2 quarters
Shell PLC 0.1% 527,400 30.0M USD −37.9% reduced Q1 2022 4 quarters
Bicycle Therapeutics PLC 0.1% 1,007,978 29.8M USD −19.7% reduced Q4 2019 13 quarters
Haemonetics Corp Mass 0.1% 373,846 29.4M USD −32.9% reduced Q2 2022 3 quarters
Enerplus Corp 0.1% 1,650,519 29.1M USD −28.8% reduced Q4 2018 17 quarters
Foot Locker Inc 0.1% 750,071 28.3M USD −18.7% reduced Q3 2022 2 quarters
Aclaris Therapeutics Inc 0.1% 1,782,600 28.1M USD −3.8% reduced Q1 2021 8 quarters
GM General Motors 0.1% 820,690 27.6M USD −80.1% reduced Q2 2020 11 quarters
Juniper Networks Inc 0.1% 827,211 26.4M USD −86.8% reduced Q3 2021 6 quarters
IBKR Interactive Brokers < 0.1% 357,400 25.9M USD −10.7% reduced Q2 2022 3 quarters
Insmed Inc < 0.1% 1,291,580 25.8M USD −16.2% reduced Q3 2018 18 quarters
Corebridge Finl Inc < 0.1% 1,273,754 25.6M USD −26.4% reduced Q3 2022 2 quarters
Jack In The Box Inc < 0.1% 361,404 24.7M USD −51.6% reduced Q3 2022 2 quarters
Sanofi < 0.1% 500,000 24.2M USD −71.1% reduced Q1 2018 20 quarters
Pbf Energy Inc < 0.1% 588,600 24.0M USD −14.4% reduced Q1 2022 4 quarters
ETR Entergy < 0.1% 212,568 23.9M USD −56.5% reduced Q1 2022 4 quarters
Fluor Corp New < 0.1% 680,000 23.6M USD −53.0% reduced Q2 2022 3 quarters
Point Biopharma Global Inc < 0.1% 3,197,565 23.3M USD −13.4% reduced Q1 2022 4 quarters
DXCM Dexcom < 0.1% 202,835 23.0M USD −75.6% reduced Q2 2022 3 quarters
APTV Aptiv < 0.1% 245,508 22.9M USD −72.3% reduced Q4 2021 5 quarters
NI NiSource < 0.1% 792,600 21.7M USD −57.6% reduced Q3 2022 2 quarters
GDDY GoDaddy < 0.1% 289,861 21.7M USD −68.4% reduced Q3 2021 6 quarters
Quidelortho Corp < 0.1% 251,400 21.5M USD −76.8% reduced Q2 2022 3 quarters
FANG Diamondback Energy < 0.1% 148,299 20.3M USD −21.7% reduced Q3 2022 2 quarters
Floor & Decor HLDGS Inc < 0.1% 283,594 19.7M USD −58.8% reduced Q3 2022 2 quarters
APD Air Products < 0.1% 63,870 19.7M USD −68.9% reduced Q1 2022 4 quarters
Aecom < 0.1% 227,200 19.3M USD −44.3% reduced Q3 2021 6 quarters
LII Lennox International < 0.1% 77,700 18.6M USD −56.0% reduced Q4 2021 5 quarters
Sensata Technologies Hldg Pl < 0.1% 459,439 18.6M USD −8.9% reduced Q2 2022 3 quarters
Allete Inc < 0.1% 287,200 18.5M USD −16.3% reduced Q2 2020 11 quarters
East West Bancorp Inc < 0.1% 280,804 18.5M USD −46.3% reduced Q1 2022 4 quarters
Select Sector SPDR TR < 0.1% 210,000 18.4M USD −90.0% reduced Q1 2019 16 quarters
RSG Republic Services < 0.1% 140,433 18.1M USD −27.3% reduced Q2 2022 3 quarters
Axogen Inc < 0.1% 1,815,000 18.1M USD −16.2% reduced Q2 2022 3 quarters
Marqeta Inc < 0.1% 2,950,000 18.0M USD −12.8% reduced Q4 2021 5 quarters
PSA Public Storage < 0.1% 64,261 18.0M USD −50.6% reduced Q2 2022 3 quarters
EVRG Evergy < 0.1% 278,600 17.5M USD −12.6% reduced Q3 2022 2 quarters
SPDR S&P 500 ETF TR < 0.1% 44,000 16.8M USD −35.3% reduced Q1 2022 4 quarters
Elastic N V < 0.1% 324,965 16.7M USD −26.9% reduced Q2 2020 11 quarters
AME Ametek < 0.1% 119,302 16.7M USD −15.4% reduced Q3 2021 6 quarters
Health Catalyst Inc < 0.1% 1,566,000 16.6M USD −18.8% reduced Q1 2022 4 quarters
Netstreit Corp < 0.1% 905,595 16.6M USD −9.9% reduced Q1 2022 4 quarters
Arcutis Biotherapeutics Inc < 0.1% 1,103,576 16.3M USD −70.8% reduced Q3 2020 10 quarters
Dyne Therapeutics Inc < 0.1% 1,387,668 16.1M USD −7.3% reduced Q1 2021 8 quarters
Pvh Corporation < 0.1% 223,813 15.8M USD −42.4% reduced Q4 2020 9 quarters
GS Goldman Sachs < 0.1% 45,646 15.7M USD −41.3% reduced Q2 2022 3 quarters
Stag Indl Inc < 0.1% 473,221 15.3M USD −23.5% reduced Q4 2021 5 quarters
Karuna Therapeutics Inc < 0.1% 76,992 15.1M USD −71.3% reduced Q3 2022 2 quarters
FLEX Flex Ltd. < 0.1% 703,900 15.1M USD −69.4% reduced Q1 2022 4 quarters
Cyberark Software Ltd < 0.1% 112,800 14.6M USD −50.2% reduced Q3 2022 2 quarters
Vaxcyte Inc < 0.1% 302,600 14.5M USD −28.4% reduced Q3 2022 2 quarters
Repligen Corp < 0.1% 84,178 14.3M USD −72.6% reduced Q3 2018 18 quarters
Esperion Therapeutics Inc Ne < 0.1% 2,277,000 14.2M USD −18.3% reduced Q2 2022 3 quarters
Transalta Corp < 0.1% 1,569,275 14.0M USD −13.3% reduced Q3 2020 10 quarters
Ishares TR < 0.1% 80,000 13.9M USD −7.9% reduced Q2 2022 3 quarters
Woodward Inc < 0.1% 143,200 13.8M USD −14.7% reduced Q3 2021 6 quarters
Performance Food Group Co < 0.1% 228,841 13.4M USD −42.7% reduced Q2 2019 15 quarters
Boot Barn HLDGS Inc < 0.1% 213,526 13.3M USD −15.7% reduced Q3 2022 2 quarters
Si-Bone Inc < 0.1% 951,800 12.9M USD −27.0% reduced Q1 2022 4 quarters
Cerevel Therapeutics Hldng I < 0.1% 403,129 12.7M USD −62.8% reduced Q2 2022 3 quarters
Jfrog Ltd < 0.1% 595,292 12.7M USD −71.9% reduced Q3 2021 6 quarters
Air Lease Corp < 0.1% 328,800 12.6M USD −24.7% reduced Q2 2022 3 quarters
Merit Med Sys Inc < 0.1% 177,649 12.5M USD −15.4% reduced Q2 2021 7 quarters
Bill Com HLDGS Inc < 0.1% 114,822 12.5M USD −89.3% reduced Q2 2020 11 quarters
FSLR First Solar < 0.1% 82,569 12.4M USD −68.4% reduced Q1 2022 4 quarters
ALLE Allegion < 0.1% 116,120 12.2M USD −61.7% reduced Q2 2022 3 quarters
APA APA Corporation < 0.1% 261,403 12.2M USD −91.6% reduced Q1 2021 8 quarters
VIPS Vipshop < 0.1% 893,300 12.2M USD −3.8% reduced Q2 2022 3 quarters
Civitas Resources Inc < 0.1% 206,770 12.0M USD −14.4% reduced Q2 2022 3 quarters
Invesco QQQ TR < 0.1% 44,600 11.9M USD −22.3% reduced Q2 2022 3 quarters
DLR Digital Realty < 0.1% 118,100 11.8M USD −82.6% reduced Q3 2021 6 quarters
Middleby Corp < 0.1% 88,000 11.8M USD −46.6% reduced Q3 2022 2 quarters
Equity Residential < 0.1% 196,455 11.6M USD −42.6% reduced Q4 2021 5 quarters
CMI Cummins < 0.1% 47,576 11.5M USD −45.1% reduced Q3 2022 2 quarters
Smucker J M Co < 0.1% 68,500 10.9M USD −77.6% reduced Q3 2022 2 quarters
Radnet Inc < 0.1% 565,930 10.7M USD −68.8% reduced Q2 2020 11 quarters
Phreesia Inc < 0.1% 325,653 10.5M USD −47.4% reduced Q1 2022 4 quarters
Repay HLDGS Corp < 0.1% 1,280,023 10.3M USD −18.9% reduced Q3 2021 6 quarters
Intra-Cellular Therapies Inc < 0.1% 194,152 10.3M USD −70.4% reduced Q3 2022 2 quarters
Cameco Corp < 0.1% 450,700 10.2M USD −43.2% reduced Q1 2021 8 quarters
NOC Northrop Grumman < 0.1% 17,418 9.5M USD −87.7% reduced Q2 2022 3 quarters
Bread Financial Holdings Inc < 0.1% 249,821 9.4M USD 0.0% reduced Q4 2018 17 quarters
CSGP CoStar Group < 0.1% 121,355 9.4M USD −69.7% reduced Q1 2022 4 quarters
Radius Global Infrastrctre I < 0.1% 779,629 9.2M USD −5.8% reduced Q4 2021 5 quarters
Essential Utils Inc < 0.1% 192,911 9.2M USD −8.5% reduced Q3 2021 6 quarters
BSX Boston Scientific < 0.1% 197,869 9.2M USD −93.2% reduced Q3 2021 6 quarters
FITB Fifth Third Bancorp < 0.1% 275,412 9.0M USD −60.7% reduced Q2 2022 3 quarters
Inmode Ltd < 0.1% 244,700 8.7M USD −76.2% reduced Q2 2022 3 quarters
Tronox Holdings PLC < 0.1% 625,349 8.6M USD −10.0% reduced Q4 2020 9 quarters
The Beauty Health Company < 0.1% 907,770 8.3M USD −48.2% reduced Q2 2022 3 quarters
Planet Fitness Inc < 0.1% 103,700 8.2M USD −5.5% reduced Q1 2022 4 quarters
Booz Allen Hamilton Hldg Cor < 0.1% 77,900 8.1M USD −72.6% reduced Q2 2021 7 quarters
Nexgen Energy Ltd < 0.1% 1,808,000 8.0M USD −14.9% reduced Q3 2022 2 quarters
MET MetLife < 0.1% 108,066 7.8M USD −82.7% reduced Q1 2021 8 quarters
Viridian Therapeutics Inc < 0.1% 260,091 7.6M USD −9.3% reduced Q1 2021 8 quarters
Webster Finl Corp < 0.1% 156,327 7.4M USD −33.2% reduced Q1 2022 4 quarters
Nmi HLDGS Inc < 0.1% 350,000 7.3M USD −20.2% reduced Q2 2022 3 quarters
Masimo Corp < 0.1% 48,500 7.2M USD −76.1% reduced Q3 2022 2 quarters
Veradigm Inc < 0.1% 401,900 7.1M USD −59.0% reduced Q2 2022 3 quarters
Halozyme Therapeutics Inc < 0.1% 122,000 6.9M USD −59.8% reduced Q3 2022 2 quarters
Healthcare Rlty TR < 0.1% 360,095 6.9M USD −55.0% reduced Q3 2022 2 quarters
Kohls Corp < 0.1% 260,833 6.6M USD −31.7% reduced Q1 2022 4 quarters
Ryman Hospitality Pptys Inc < 0.1% 77,856 6.4M USD −46.2% reduced Q1 2022 4 quarters
Cenovus Energy Inc < 0.1% 326,632 6.3M USD −96.1% reduced Q3 2022 2 quarters
Potlatchdeltic Corporation < 0.1% 143,800 6.3M USD −47.2% reduced Q3 2022 2 quarters
Perrigo Co PLC < 0.1% 181,300 6.2M USD −90.1% reduced Q2 2022 3 quarters
Mdu Res Group Inc < 0.1% 195,700 5.9M USD −36.2% reduced Q1 2022 4 quarters
Brp Group Inc < 0.1% 225,327 5.7M USD −46.2% reduced Q3 2021 6 quarters
Arch Resources Inc < 0.1% 39,120 5.6M USD −44.9% reduced Q2 2022 3 quarters
Bioatla Inc < 0.1% 649,680 5.4M USD −15.0% reduced Q3 2022 2 quarters
FIVE9 Inc < 0.1% 78,650 5.3M USD −75.1% reduced Q4 2021 5 quarters
Affimed N V < 0.1% 4,207,220 5.2M USD −21.9% reduced Q3 2019 14 quarters
Dun & Bradstreet HLDGS Inc < 0.1% 424,908 5.2M USD −33.8% reduced Q3 2022 2 quarters
BAC Bank of America < 0.1% 151,970 5.0M USD −68.8% reduced Q1 2022 4 quarters
FDS FactSet < 0.1% 12,400 5.0M USD −78.6% reduced Q1 2022 4 quarters
MELI MercadoLibre < 0.1% 5,719 4.8M USD −93.7% reduced Q3 2022 2 quarters
VICI Vici Properties < 0.1% 146,353 4.7M USD −75.3% reduced Q1 2022 4 quarters
Alphatec HLDGS Inc < 0.1% 379,300 4.7M USD −58.6% reduced Q4 2020 9 quarters
Antero Midstream Corp < 0.1% 432,381 4.7M USD −9.9% reduced Q2 2022 3 quarters
ILMN Illumina, Inc. < 0.1% 23,006 4.7M USD −95.4% reduced Q3 2022 2 quarters
FE FirstEnergy < 0.1% 107,597 4.5M USD −96.5% reduced Q2 2022 3 quarters
Synovus Finl Corp < 0.1% 117,314 4.4M USD −37.5% reduced Q1 2022 4 quarters
Clean Energy Fuels Corp < 0.1% 813,551 4.2M USD −39.7% reduced Q1 2022 4 quarters
Regal Rexnord Corporation < 0.1% 35,215 4.2M USD −63.1% reduced Q3 2022 2 quarters
Southwest Gas HLDGS Inc < 0.1% 67,900 4.2M USD −73.0% reduced Q4 2021 5 quarters
MAR Marriott International < 0.1% 27,286 4.1M USD −93.5% reduced Q3 2022 2 quarters
Seres Therapeutics Inc < 0.1% 699,600 3.9M USD −25.5% reduced Q2 2022 3 quarters
Axalta Coating Sys Ltd < 0.1% 152,440 3.9M USD −73.8% reduced Q3 2022 2 quarters
Allison Transmission HLDGS I < 0.1% 90,747 3.8M USD −14.6% reduced Q3 2022 2 quarters
Accolade Inc < 0.1% 482,700 3.8M USD −13.5% reduced Q3 2022 2 quarters
Evgo Inc < 0.1% 801,110 3.6M USD −14.8% reduced Q3 2022 2 quarters
Angi Inc < 0.1% 1,504,814 3.5M USD −19.8% reduced Q2 2020 11 quarters
OPEN Opendoor Technologies < 0.1% 3,024,630 3.5M USD −23.1% reduced Q3 2021 6 quarters
Protagonist Therapeutics Inc < 0.1% 316,500 3.5M USD −87.5% reduced Q4 2020 9 quarters
Apple Hospitality REIT Inc < 0.1% 217,085 3.4M USD −23.5% reduced Q2 2022 3 quarters
Delek US HLDGS Inc New < 0.1% 121,000 3.3M USD −73.7% reduced Q3 2022 2 quarters
Nvent Electric PLC < 0.1% 84,479 3.2M USD −47.3% reduced Q3 2022 2 quarters
4D Molecular Therapeutics In < 0.1% 139,300 3.1M USD −53.4% reduced Q3 2022 2 quarters
Tripadvisor Inc < 0.1% 166,900 3.0M USD −10.2% reduced Q3 2022 2 quarters
Rli Corp < 0.1% 21,300 2.8M USD −74.9% reduced Q3 2022 2 quarters
Lexicon Pharmaceuticals Inc < 0.1% 1,344,131 2.6M USD −62.8% reduced Q3 2022 2 quarters
Helix Energy Solutions Grp I < 0.1% 326,000 2.4M USD −13.0% reduced Q3 2022 2 quarters
Cepton Inc < 0.1% 1,813,535 2.3M USD −3.6% reduced Q1 2022 4 quarters
Arrowhead Pharmaceuticals In < 0.1% 56,652 2.3M USD −91.5% reduced Q2 2021 7 quarters
DKNG DraftKings < 0.1% 189,735 2.2M USD −79.1% reduced Q1 2022 4 quarters
CVNA Carvana < 0.1% 447,121 2.1M USD −63.0% reduced Q1 2022 4 quarters
Intercept Pharmaceuticals In < 0.1% 166,300 2.1M USD −89.3% reduced Q3 2021 6 quarters
Angiodynamics Inc < 0.1% 139,754 1.9M USD −78.7% reduced Q4 2020 9 quarters
Jazz Pharmaceuticals PLC < 0.1% 11,800 1.9M USD −97.0% reduced Q3 2021 6 quarters
Enact HLDGS Inc < 0.1% 75,000 1.8M USD −32.8% reduced Q1 2022 4 quarters
SPDR Ser TR < 0.1% 13,200 1.8M USD −22.4% reduced Q3 2022 2 quarters
Denali Therapeutics Inc < 0.1% 64,400 1.8M USD −89.8% reduced Q3 2022 2 quarters
Coty Inc < 0.1% 202,717 1.7M USD −81.9% reduced Q2 2021 7 quarters
Berry Global Group Inc < 0.1% 24,000 1.5M USD −97.1% reduced Q2 2021 7 quarters
STT State Street Corporation < 0.1% 18,520 1.4M USD −86.0% reduced Q2 2022 3 quarters
ROST Ross Stores < 0.1% 12,236 1.4M USD −99.3% reduced Q4 2021 5 quarters
Dxc Technology Co < 0.1% 51,200 1.4M USD −96.3% reduced Q3 2022 2 quarters
DIS Walt Disney Company (The) < 0.1% 15,332 1.3M USD −98.1% reduced Q4 2021 5 quarters
Li-Cycle Holdings Corp < 0.1% 279,300 1.3M USD −16.0% reduced Q1 2022 4 quarters
Achilles Therapeutics PLC < 0.1% 1,413,809 1.3M USD −32.9% reduced Q3 2021 6 quarters
Talkspace Inc < 0.1% 2,050,000 1.3M USD −36.4% reduced Q2 2022 3 quarters
Advanced Drain Sys Inc Del < 0.1% 15,000 1.2M USD −91.6% reduced Q1 2022 4 quarters
Employers HLDGS Inc < 0.1% 28,000 1.2M USD −7.6% reduced Q3 2021 6 quarters
FFIV F5, Inc. < 0.1% 7,900 1.1M USD −97.6% reduced Q3 2022 2 quarters
Arcturus Therapeutics HLDGS < 0.1% 64,500 1.1M USD −89.5% reduced Q1 2022 4 quarters
LNT Alliant Energy < 0.1% 19,100 1.1M USD −91.5% reduced Q2 2022 3 quarters
Championx Corporation < 0.1% 35,000 1.0M USD −80.7% reduced Q3 2022 2 quarters
Immunic Inc < 0.1% 714,655 1.0M USD −46.1% reduced Q3 2021 6 quarters
Alx Oncology HLDGS Inc < 0.1% 85,000 958.0K USD −77.8% reduced Q3 2022 2 quarters
Lifecore Biomedical Inc < 0.1% 141,446 916.6K USD −24.0% reduced Q4 2021 5 quarters
ADSK Autodesk < 0.1% 4,901 915.9K USD −96.8% reduced Q2 2022 3 quarters
Transocean Ltd < 0.1% 193,108 880.6K USD −65.7% reduced Q1 2022 4 quarters
REG Regency Centers < 0.1% 13,900 868.8K USD −86.6% reduced Q3 2022 2 quarters
Aligos Therapeutics Inc < 0.1% 905,896 863.2K USD −1.2% reduced Q3 2021 6 quarters
Aadi Bioscience Inc < 0.1% 66,066 847.6K USD −88.4% reduced Q1 2022 4 quarters
Ishares TR < 0.1% 20,100 761.8K USD −94.6% reduced Q2 2022 3 quarters
Globalstar Inc < 0.1% 498,500 663.0K USD −78.8% reduced Q3 2022 2 quarters
Childrens Pl Inc New < 0.1% 18,200 662.8K USD −91.3% reduced Q1 2019 16 quarters
X4 Pharmaceuticals Inc < 0.1% 650,000 645.5K USD −74.5% reduced Q4 2021 5 quarters
Mediaalpha Inc < 0.1% 64,000 636.8K USD −66.7% reduced Q3 2021 6 quarters
Northwestern Corp < 0.1% 10,600 629.0K USD −93.1% reduced Q2 2022 3 quarters
Blackline Inc < 0.1% 8,700 585.2K USD −91.4% reduced Q3 2022 2 quarters
Fulgent Genetics Inc < 0.1% 18,800 559.9K USD −88.3% reduced Q3 2021 6 quarters
Applied Therapeutics Inc < 0.1% 719,938 547.2K USD −58.1% reduced Q1 2020 12 quarters
CBRE CBRE Group < 0.1% 6,800 523.3K USD −95.5% reduced Q1 2022 4 quarters
Albireo Pharma Inc < 0.1% 24,200 523.0K USD −69.0% reduced Q3 2022 2 quarters
Ishares TR < 0.1% 10,000 498.2K USD −50.0% reduced Q1 2020 12 quarters
Wave Life Sciences Ltd < 0.1% 63,600 445.2K USD −93.9% reduced Q3 2022 2 quarters
Century Therapeutics Inc < 0.1% 82,100 421.2K USD −50.3% reduced Q4 2021 5 quarters
Buckle Inc < 0.1% 9,100 412.7K USD −96.5% reduced Q3 2022 2 quarters
Sony Group Corporation < 0.1% 5,137 391.9K USD −67.3% reduced Q2 2022 3 quarters
Myriad Genetics Inc < 0.1% 26,800 388.9K USD −93.4% reduced Q1 2022 4 quarters
Brc Inc < 0.1% 60,900 372.1K USD −92.3% reduced Q3 2022 2 quarters
Arrival < 0.1% 2,180,000 347.7K USD −15.5% reduced Q3 2022 2 quarters
Sweetgreen Inc < 0.1% 36,700 314.5K USD −69.8% reduced Q3 2022 2 quarters
Bjs Restaurants Inc < 0.1% 10,700 282.3K USD −96.0% reduced Q2 2022 3 quarters
Arcelormittal SA Luxembourg < 0.1% 10,445 273.9K USD −45.0% reduced Q2 2022 3 quarters
Aeva Technologies Inc < 0.1% 189,600 257.9K USD −51.9% reduced Q3 2022 2 quarters
Centessa Pharmaceuticals PLC < 0.1% 79,700 247.1K USD −32.3% reduced Q2 2021 7 quarters
Gh Research PLC < 0.1% 24,600 239.1K USD −87.9% reduced Q4 2021 5 quarters
Foghorn Therapeutics Inc < 0.1% 33,000 210.5K USD −91.5% reduced Q4 2021 5 quarters
Blue Owl Capital Inc < 0.1% 19,500 206.7K USD −94.7% reduced Q3 2022 2 quarters
Electronic Arts Inc < 0.1% 1,526 186.4K USD −98.6% reduced Q2 2021 7 quarters
Lincoln Natl Corp Ind < 0.1% 5,347 164.3K USD −97.8% reduced Q3 2021 6 quarters
First Watch Restaurant Group < 0.1% 10,504 142.1K USD −90.6% reduced Q2 2022 3 quarters
VTRS Viatris < 0.1% 12,347 137.4K USD −99.3% reduced Q3 2022 2 quarters
Ares Acquisition Corporation < 0.1% 275,000 128.2K USD −14.1% reduced Q1 2022 4 quarters
Tusimple HLDGS Inc < 0.1% 72,097 118.2K USD −53.3% reduced Q3 2021 6 quarters
Duck Creek Technologies Inc < 0.1% 7,700 92.8K USD −81.8% reduced Q2 2022 3 quarters
PEP PepsiCo < 0.1% 441 79.7K USD −99.9% reduced Q3 2022 2 quarters
Neoleukin Therapeutics Inc < 0.1% 136,675 69.6K USD −93.4% reduced Q4 2019 13 quarters
Chindata Group HLDGS Ltd < 0.1% 7,200 57.4K USD −89.9% reduced Q2 2022 3 quarters
UNH UnitedHealth Group < 0.1% 96 50.9K USD −99.9% reduced Q3 2022 2 quarters
Aurora Innovation Inc < 0.1% 30,000 36.3K USD −59.6% reduced Q4 2021 5 quarters
COIN Coinbase < 0.1% 469 16.6K USD −97.8% reduced Q2 2022 3 quarters
Sonic Automotive Inc < 0.1% 200 9.9K USD −99.5% reduced Q3 2022 2 quarters
D-Wave Quantum Inc < 0.1% 33,333 3.5K USD −41.2% reduced Q3 2022 2 quarters
Adicet Bio Inc < 0.1% 300 2.7K USD −99.7% reduced Q1 2021 8 quarters
Churchill Capital Corp Vii < 0.1% 14,000 692.0 USD −6.7% reduced Q1 2022 4 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 400 option positions, value of the underlying shares as reported 2.9B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 479.8M USD
  • SPDR S&P 500 ETF TR Call 266.2M USD
  • Humana Put 196.9M USD
  • UnitedHealth Group Put 196.8M USD
  • Invesco Db Multi-Sector Comm Call 90.7M USD
  • Caterpillar Inc. Put 70.4M USD
  • Select Sector SPDR TR Put 57.4M USD
  • IBM Put 53.6M USD
  • Medical Pptys Trust Inc Put 51.2M USD
  • AstraZeneca Call 49.9M USD
Plus 52 positions in convertible bonds and bonds worth 472.4M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Novavax Inc principal 29.9M USD 29.8M USD
  • Ringcentral Inc principal 27.7M USD 23.9M USD
  • Unity Software Inc principal 30.0M USD 22.6M USD
  • Splunk Inc principal 21.0M USD 20.3M USD
  • Spotify USA Inc principal 24.5M USD 19.8M USD
  • Docusign Inc principal 18.5M USD 17.5M USD
  • Dish Network Corporation principal 27.0M USD 17.3M USD
  • Dish Network Corporation principal 19.0M USD 17.1M USD
  • Splunk Inc principal 18.0M USD 17.0M USD
  • Sarepta Therapeutics Inc principal 9.0M USD 16.8M USD

Breakdown by sector

  • Technology 12.1%
  • Financials 7.3%
  • Consumer Discretionary 7.0%
  • Industrials 6.5%
  • Health Care 5.7%
  • Communication Services 5.4%
  • Utilities 3.5%
  • Consumer Staples 2.5%
  • Energy 2.3%
  • Materials 1.2%
  • Real Estate 0.7%
  • not in our coverage 45.9%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close